Published in Br J Surg on March 01, 2005
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci (2006) 1.18
Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg (2013) 1.10
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer (2008) 1.08
Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis. ISRN Oncol (2011) 0.99
Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer. World J Surg (2012) 0.99
The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging (2008) 0.98
Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol (2008) 0.97
Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) (2011) 0.93
Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease. Int Semin Surg Oncol (2007) 0.86
Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB (Oxford) (2014) 0.85
Laparoscopic staging in selected patients with colorectal liver metastases as a prelude to liver resection. HPB (Oxford) (2007) 0.83
Metachronous liver metastases and resectability: Fong's score and laparoscopic evaluation. HPB (Oxford) (2008) 0.78
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep (2015) 0.78
Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer. Strahlenther Onkol (2009) 0.77
Positron emission tomography for staging and assessment of tumor response of hepatic malignancies. Semin Intervent Radiol (2006) 0.77
Colorectal hepatic metastasis: Evolving therapies. World J Hepatol (2014) 0.77
The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis. Ann R Coll Surg Engl (2014) 0.76
PET: too much of a good thing? Does the plethora of choices impact on patient management? Eur J Nucl Med Mol Imaging (2005) 0.75
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol (1990) 1.78
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res (2000) 1.45
[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40
[Evaluation of a new sequence of magnetic resonance cholangio-pancreatography in thick cut and one shot acquisition]. Gastroenterol Clin Biol (2000) 1.40
[Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]. Rev Med Interne (1993) 1.39
'Normal' 99mTc-HmPAO distribution in large subacute middle cerebral artery infarct. Stroke (1994) 1.39
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res (1998) 1.32
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia (1993) 1.29
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther (2003) 1.25
Arterial complications of percutaneous transhepatic biliary drainage. Cardiovasc Intervent Radiol (1996) 1.18
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score. Aliment Pharmacol Ther (2011) 1.17
Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study. Surg Endosc (2011) 1.16
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene (2012) 1.11
Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol (1996) 1.11
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int (2005) 1.10
[Paragangliomas: clinical and secretory profile. Result of 39 cases]. Ann Chir (2004) 1.09
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry (1991) 1.07
Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroenterol Clin Biol (2009) 1.06
Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res (2001) 1.05
Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery (1998) 1.01
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'. Br J Cancer (2006) 0.99
Basic fibroblast growth factor receptors and their prognostic value in human breast cancer. Clin Cancer Res (1998) 0.98
SPECT data in a case of secondary Capgras delusion. Psychopathology (1994) 0.97
Radionuclide scanning in parathyroid diseases. Br J Surg (1998) 0.97
Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol (2012) 0.94
Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry (2000) 0.94
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. Br J Cancer (2009) 0.94
FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study. Ann Oncol (2010) 0.93
[Retrorectal tumors: an assessment of the abdominal approach]. Ann Chir (2001) 0.93
Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques. Br J Haematol (1996) 0.92
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. J Nucl Med (1998) 0.91
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study. Ann Oncol (2006) 0.91
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med (2001) 0.90
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6. Oncology (2011) 0.89
[Cerebral blood flow disturbances after anterior choroidal artery infarcts. Anatomical and functional correlates]. Rev Neurol (Paris) (2001) 0.88
Caroli's disease: a magnetic resonance cholangiopancreatography diagnosis. Am J Gastroenterol (1998) 0.88
Evidence for atrophy of the corpus callosum in Alzheimer's disease. Eur Neurol (1994) 0.87
Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery (1998) 0.87
Relationship between parity and clinical and biological features in patients with systemic sclerosis. J Rheumatol (2001) 0.86
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases. Br J Cancer (2004) 0.86
Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas. Surgery (1996) 0.86
Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Acta Neurol Scand (1995) 0.86
Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography. Neuroradiology (2002) 0.86
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus (2004) 0.85
[Leiomyosarcoma and stromal tumor of the pancreas]. J Radiol (2001) 0.85
[Dermoid cyst of the diaphragm: a case report]. J Chir (Paris) (2009) 0.84
3D mutifractal analysis: a new tool for epileptic fit sources detection in SPECT images. Conf Proc IEEE Eng Med Biol Soc (2008) 0.83
Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three cases. J Chemother (2008) 0.83
[Correlation of thalamic aphasia and cerebral blood flow]. Rev Neurol (Paris) (1990) 0.82
Age as a prognostic factor in breast cancer. Anticancer Res (1998) 0.82
Hepatic iron overload: quantification with MR imaging at 1.5 T. AJR Am J Roentgenol (1999) 0.82
[Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients]. Rev Med Interne (2001) 0.82
Fractal features for localization of temporal lobe epileptic foci using SPECT imaging. Comput Biol Med (2010) 0.81
Stable labelling of serum albumin microspheres with gallium-68. Int J Rad Appl Instrum A (1986) 0.81
[Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with scleroderma]. Rev Med Interne (1997) 0.81
Remote regional cerebral blood flow consequences of focused infarcts of the medulla, pons and cerebellum. J Nucl Med (1999) 0.81
Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma. Aust N Z J Surg (1999) 0.81
Management of blunt hepatic trauma. J Visc Surg (2010) 0.81
Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med (1999) 0.80
Torsion of a fatty fringe of the falciform ligament, a rare cause of right hypochondrial pain. Diagn Interv Imaging (2013) 0.80
[Acute pancreatitis, systemic lupus and antiphospholipid syndrome. 2 cases]. Rev Med Interne (1994) 0.80
[Residual deficit of verbal recall after a left internal cerebral vein infarct]. Rev Neurol (Paris) (1998) 0.80
[Alzheimer's disease: study by single photon emission tomography (Hm PAO Tc99m)]. Rev Neurol (Paris) (1989) 0.80
Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis. Am J Med (1996) 0.80
Tomographic measurement of cerebral blood flow by the 68Ga-labelled-microsphere and continuous-C15O2-inhalation methods. Eur J Nucl Med (1985) 0.80
[The association of asthma and gastroesophageal reflux: strategy of paraclinical studies]. Rev Mal Respir (1985) 0.79
[Pancreatic lipomatosis revealing Johanson-Blizzard syndrome]. Gastroenterol Clin Biol (1999) 0.79
Crossed hemispheric diaschisis in unilateral cerebellar lesions. Stroke (1992) 0.79
[The delusion of place: contribution of the measurement of cerebral deficit]. Cortex (1988) 0.79
Surgical management of liver metastases from gastrointestinal endocrine tumors. Gastroenterol Clin Biol (2010) 0.79
Differential diagnosis and prognosis of T1-weighted post-gadolinium intralabyrinthine hyperintensities. Eur Radiol (2010) 0.79
[Yellow nail syndrome associated with rheumatoid arthritis. Regression under chrysotherapy]. Rev Med Interne (1997) 0.79
[Wegener's granulomatosis in the elderly patient]. Rev Med Interne (2001) 0.79
Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7. Mol Cell Biol Res Commun (2000) 0.79
[Dystonia and tremor in bilateral lesion of the posterior mesencephalon and the vermis]. Rev Neurol (Paris) (1996) 0.79
Xerostomia in systemic sclerosis: systematic evaluation by salivary scintigraphy and lip biopsy in thirty-four patients. Arthritis Rheum (1994) 0.79
[Disruptions of hemispheric blood flow and deep cerebral hematomas]. Rev Neurol (Paris) (1986) 0.79
[HmPaO Tc as an indicator of local cerebral blood flow: quantified study compared to the xenon 133 inhalation method]. Ann Radiol (Paris) (1988) 0.79
[Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)]. Bull Cancer (2004) 0.78
[Validity of the intracystic tumoral markers for the diagnosis of the cystic tumors of the pancreas]. Gastroenterol Clin Biol (2009) 0.78
Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med (2001) 0.78
Perfusion mapping with Tc-HMPAO in cerebral haematomas. J Neurol Neurosurg Psychiatry (1991) 0.78
Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine. Aust N Z J Surg (1998) 0.78
Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide. J Nucl Med (1994) 0.78
[Right unilateral auditory agnosia following left lenticular hemorrhage]. Rev Neurol (Paris) (1991) 0.78
Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma. Q J Nucl Med Mol Imaging (2012) 0.78
PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism. J Neural Transm (Vienna) (1998) 0.78
A new method based on both fuzzy set and possibility theories for tumor volume segmentation on PET images. Conf Proc IEEE Eng Med Biol Soc (2008) 0.77